FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer

Carine Pecqueux, Ayşenur Arslan, Martina Heller, Michael Falkenstein, Adam Kaczorowski, Yanis Tolstov, Holger Sültmann, Carsten Grüllich, Esther Herpel, Anette Duensing,

Urologic Oncology Seminars and Original Investigations · 2018 · 21 citations · 28 references

Concepts

References

28